1. Home
  2. ELUT vs IDR Comparison

ELUT vs IDR Comparison

Compare ELUT & IDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • IDR
  • Stock Information
  • Founded
  • ELUT 2015
  • IDR 1996
  • Country
  • ELUT United States
  • IDR United States
  • Employees
  • ELUT N/A
  • IDR N/A
  • Industry
  • ELUT Medical Specialities
  • IDR Precious Metals
  • Sector
  • ELUT Health Care
  • IDR Basic Materials
  • Exchange
  • ELUT Nasdaq
  • IDR Nasdaq
  • Market Cap
  • ELUT 128.3M
  • IDR 142.7M
  • IPO Year
  • ELUT 2020
  • IDR N/A
  • Fundamental
  • Price
  • ELUT $3.22
  • IDR $12.66
  • Analyst Decision
  • ELUT Strong Buy
  • IDR Strong Buy
  • Analyst Count
  • ELUT 2
  • IDR 1
  • Target Price
  • ELUT $10.00
  • IDR $14.00
  • AVG Volume (30 Days)
  • ELUT 37.7K
  • IDR 183.5K
  • Earning Date
  • ELUT 03-06-2025
  • IDR 03-24-2025
  • Dividend Yield
  • ELUT N/A
  • IDR N/A
  • EPS Growth
  • ELUT N/A
  • IDR 344.27
  • EPS
  • ELUT N/A
  • IDR 0.52
  • Revenue
  • ELUT $24,782,000.00
  • IDR $21,955,008.00
  • Revenue This Year
  • ELUT $3.88
  • IDR $86.37
  • Revenue Next Year
  • ELUT $34.52
  • IDR $11.11
  • P/E Ratio
  • ELUT N/A
  • IDR $24.54
  • Revenue Growth
  • ELUT N/A
  • IDR 64.93
  • 52 Week Low
  • ELUT $2.28
  • IDR $6.83
  • 52 Week High
  • ELUT $5.24
  • IDR $18.35
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 55.09
  • IDR 48.80
  • Support Level
  • ELUT $2.83
  • IDR $12.82
  • Resistance Level
  • ELUT $3.00
  • IDR $13.45
  • Average True Range (ATR)
  • ELUT 0.26
  • IDR 0.67
  • MACD
  • ELUT 0.09
  • IDR -0.13
  • Stochastic Oscillator
  • ELUT 91.01
  • IDR 1.08

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About IDR Idaho Strategic Resources Inc.

Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.

Share on Social Networks: